Skip to content

Evaluation of the effect of cream containing extracts of marigold, marigold and honey on pain intensity and wound healing of cesarean section and episiotomy in primiparous women.

Evaluation of the effect of cream containing extracts of marigold, marigold and honey on pain intensity and wound healing of cesarean section and episiotomy in primiparous women.

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
IRCT
Registry ID
IRCT20241207063968N1
Enrollment
160
Registered
2025-02-06
Start date
2025-02-19
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The intensity of pain and the healing rate of caesarean section and episiotomy wounds. ?????? ??? ?????????????? ? ??????

Interventions

Intervention 1: Intervention Group: Women who have undergone cesarean section and episiotomy and use a cream containing comfrey, chamomile, and honey. Intervention 2: Control group: women who have und

Sponsors

Tehran Islamic Azad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Primiparous women

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Pain Intensity. Timepoint: Both interventions will be performed for 15 days. Before the intervention, 5, 10 and 15 days (after episiotomy and cesarean section) according to the protocol of the Ministry of Health. Method of measurement: Visual Analogue Scale.

Secondary

MeasureTime frame
Repair of caesarean section wound and episiotomy wound. Timepoint: Before the intervention, day 5, 10 and 15 after the intervention. Method of measurement: By examining bruising, discharge, pain, swelling, redness, and distance between the two edges of the wound.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh Zareie

Tehran Islamic Azad University of Medical Sciences

midwiferysaveh@gmail.com+98 86 4222 6996

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026